HealthQuill Articles by: HealthQuill
AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.
Drugs Medical Pharma

UK researchers get $2.1 million to develop lung cancer vaccine

HQ Team March 23, 2024: Researchers in the UK have won a grant of $2.14 million (€1.98 million) from the Cancer Research UK

Read More
Food crisis
Climate Health Medical

Urban dwellers losing their ability to digest plant cellulose

HQ Team March 22, 2024: A recent study titled “Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans” says that urban dwellers are

Read More
Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified pig, according to a statement from Massachusetts General Hospital.
Drugs Health Pharma

First genetically edited pig kidney gets transplanted into a human

HQ Team March 21, 2024: Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified

Read More
An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark of Parkinson’s disease — can be detected with high accuracy by a simple biopsy test, researchers say.
Drugs Health Pharma

Simple skin biopsy test can detect Parkinson’s disease: Harvard study

HQ Team March 21, 2024: An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark

Read More
Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and a video game using the device, according to a video posted by billionaire Elon Musk’s X platform.
Drugs Health Medical

Neuralink’s first brain implant human plays chess, video game online

HQ Team March 21, 2024: Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and

Read More
A panel consisting of Nobel laureates, former presidents and prime ministers has urged global negotiators of WHO member states to redouble their efforts to reach a consensus on the Pandemic Accord.
Drugs Health Pharma

Negotiators must close Pandemic Accord talks fast: Global panel

HQ Team March 21, 2024: A panel consisting of Nobel laureates, former presidents and prime ministers have urged global negotiators of WHO member

Read More
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Drugs Health Pharma

Bristol Myers says liver cancer therapy trial improves overall survival rate

HQ Team March 20, 2024: Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival

Read More
The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study by the National Institutes of Health (NIH).
Drugs Health Pharma

Severe Covid-19 infection can cause heart damage: NIH study says

HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study

Read More
The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.
Drugs Health Pharma

First late-stage trial vaccine doses begin in South Africa for tuberculosis

 HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Health Pharma

AstraZeneca to acquire Fusion Pharmaceuticals for $2 billion in cash

HQ Team March 20, 2024: Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the

Read More